CORVUS PHARMACEUTICALS
8.8000
07-November-24 14:59:59
15 minutes delayed
Stocks
+0.0200
+0.23%
Today's range
8.4300 - 9.1000
ISIN
N/A
Source
NASDAQ
-
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results
29 Apr 2021 15:05:01 By Nasdaq GlobeNewswire
-
25 Mar 2021 07:30:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
05 Mar 2021 07:30:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock
17 Feb 2021 15:10:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12 Feb 2021 08:00:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock
11 Feb 2021 15:01:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with COVID-19
04 Feb 2021 06:30:00 By Nasdaq GlobeNewswire